Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses컴퓨터 분석을 사용한 SARS-CoV-2 감염 관련 폐암의 잠재적 바이오마커로서의 ACE2 단백질 식별Article Published on 2020-11-012022-09-11 Journal: Genomics [Category] 바이오마커, 변종, 유전자 메커니즘, [키워드] ACE2 ACE2 expression ACE2 receptor age Analysis analyzed angiotensin-converting enzyme 2 Atla best Biomarker Biomarkers cancer patient caused Clinical characteristics co-expressed COVID-19 COVID-19 disease eight expression Factor functional Functional assessment Gender Genes Host identification interactions investigated knowledge lack lung lung adenocarcinoma lung cancer lung cancer patient lung cancer patients mechanism miRNAs mRNA expression mRNA expression analysis. pandemic performed positive Potential Potential biomarker Prognosis Protein relationship Relationship of lung cancer and COVID-19 SARS-CoV-2 SARS-COV-2 infection signaling pathway Spread survival rate susceptible TFS therapy transcription factors up-regulation was performed [DOI] 10.1016/j.ygeno.2020.09.002 PMC 바로가기 [Article Type] Article
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional SurveyOncology Published on 2020-10-142022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] addition Administered age Cancer cancer diagnosis Cancer patients changes in Comorbidity Contagion Coronavirus disease 2019 country COVID-19 COVID-19 symptoms disease disease stage division fear Fears Government highlight hospital Impact intravenous Italian Italy lockdown lung lung cancer lung cancer patient Measures pandemic Patient patient’s perception patients with comorbidity Perception Quality of life quarantine Radiotherapy reduce risk Sex survey the patient the SARS-CoV-2 Treatment women worsened [DOI] 10.3389/fonc.2020.584612 PMC 바로가기 [Article Type] Oncology
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19절박한 시간, 절박한 조치: COVID-19 치료에서 RRx-001 사례Article Published on 2020-10-012022-09-11 Journal: Seminars in oncology [Category] SARS, 신약개발, [키워드] activate acute respiratory distress acute respiratory distress syndrome acute respiratory symptom acute respiratory symptoms acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 appear approved bosentan Cancer caused Cell chronic obstructive chronic obstructive pulmonary disease clinical clinical trial clinical trials comparable coronavirus Course COVID 19 COVID-19 cytokine Cytokine storm death Deterioration Donor effective evaluated Evidence evidence of expected FDA hypertension Hypothesis ICU immune cascade Infection Inflammatory initiated less lung cancer lung cancer patient Lung infection mechanism of action Mild mild upper respiratory tract infection nitric oxide obstructive pulmonary disease oxidative pandemic Pathogenesis Patient phase phase 3 clinical trial Pneumonia preclinical studies preclinical study prodrome protective effect pulmonary disease pulmonary hypertension Pulmonary infection radiological respiratory respiratory distress Respiratory distress syndrome respiratory tract infection RRx-001 SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe pneumonia small molecule smoking syndrome the disease therapeutic activity transfer treat treated Treatment Trial upper respiratory tract upper respiratory tract infection [DOI] 10.1053/j.seminoncol.2020.07.002 PMC 바로가기 [Article Type] Article
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemicReview Published on 2020-09-232022-10-30 Journal: Infectious Agents and Cancer [Category] COVID-19, [키워드] 2019 novel coronavirus affected cancer patient Care clinical condition COVID-19 COVID-19 epidemic COVID-19 infection Epidemic growth Health Immunity increasingly International international public health lung cancer lung cancer patient management New coronavirus outbreak Patient management prevention of COVID-19 Spread spread of COVID-19 target Treatment WHO World Health Organization Wuhan, China [DOI] 10.1186/s13027-020-00322-7 PMC 바로가기 [Article Type] Review
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in MadridOncology Published on 2020-09-162022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] abnormality acute respiratory distress Admission affected Anti-viral treatment anticoagulation ARDS baseline cancer patient cancer treatment conditions coronavirus Corticosteroids cough COVID-19 COVID-19 illness D-dimer diagnosed with COVID-19 Diagnosis discharged elevated Fever fibrinogen first positive high mortality rate high variability hospital Hospitalization hospitalized patient Hydroxychloroquine Immunotherapy incidence inflammation marker Inflammatory invasive lab lung cancer lung cancer patient lung cancer patients lymphocyte measure Mortality Multiple multivariate multivariate model neutrophil no difference outcome pandemic Patient patients PCR Pneumonia PROTECT Protein receiving risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 RT-PCR Shortness of breath Spain statistically significant symptoms onset syndrome targeted therapy Tertiary therapy Thoracic time Tocilizumab Treatment variable [DOI] 10.3389/fonc.2020.01777 PMC 바로가기 [Article Type] Oncology
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative groupReview article Published on 2020-09-012022-10-05 Journal: Critical Reviews in Oncology/Hematology [Category] SARS, 치료기술, [키워드] Cancer Care Consensus country COVID-19 COVID‐19 deleted DelPhi Evidence health systems higher risk information initial lung cancer lung cancer patient lung cancer patients maintain oncology oncology patient outcome pandemic Personal protective equipment question reached recommendation recommendations SARS-CoV-2 Strong Thoracic Thoracic oncology Treatment [DOI] 10.1016/j.critrevonc.2020.103033 [Article Type] Review article
SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic ModalitiesReview Published on 2020-08-052022-10-31 Journal: Cancers [Category] COVID-19, [키워드] accompanied ACE-2 acute respiratory distress addition alveolar angiotensin-converting enzyme 2 approach bind cause cellular entry common cold complications condition coronavirus Coronaviruses COVID-19 effective drug element Genes help host proteases Human infected individuals Infectious disease inhibitors lung cancer lung cancer patient Lung injury modality morbidity and mortality pandemic patients Potential promote Protein reported Respiratory failure SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike Symptom syndrome the SARS-CoV-2 therapeutic target TMPRSS2 transmembrane serine protease Vaccine virus [DOI] 10.3390/cancers12082186 PMC 바로가기 [Article Type] Review
Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreakReview article Published on 2020-08-012022-10-05 Journal: Lung cancer (Amsterdam, Netherlands) [Category] SARS, 치료법, [키워드] affected approach Asia Cancer Care Cell China coronavirus country courses COVID-19 COVID-19 outbreak cranial deaths Essential exceptional France Health Health Service infection with COVID-19 International Italy lockdown lung cancer lung cancer patient lung cancer patients management medical condition oncology outbreak pandemic Patient postoperative Prophylactic PROTECT Radiation radiation therapy Radiotherapy recommendation resources severe pathology Spain Spread systematic review the disease Treatment [DOI] 10.1016/j.lungcan.2020.05.029 [Article Type] Review article
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus StatementResearch article Published on 2020-07-012022-10-05 Journal: International journal of radiation oncology, biolo [Category] 유전자 메커니즘, [키워드] benefit cancer patient caused characterized Consensus contributed COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 positive patient cranial DelPhi effort Factor healthcare include increased risk International joint lung cancer lung cancer patient pandemic Patient patient triage performance status postoperative Practice Pragmatic Prognosis Prophylactic provided Radiation Radiotherapy recommendation reduced resource resources Result risk Severe COVID-19 Infection susceptibility Thoracic Treatment treatment strategy were assessed [DOI] 10.1016/j.ijrobp.2020.05.012 [Article Type] Research article
Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmarkCommentary Published on 2020-06-092022-11-01 Journal: Diagnostic Pathology [Category] COVID-19, SARS, [키워드] acute lung injury caused COVID-19 COVID-19 infection COVID-19 pneumonia death diagnostic Diffuse alveolar damage Evolution feature histopathological finding Histopathology infected with COVID-19 lung lung cancer lung cancer patient mechanism non-hospitalised Oncological patient Pneumonia subject Symptoms [DOI] 10.1186/s13000-020-00990-4 PMC 바로가기 [Article Type] Commentary